122 related articles for article (PubMed ID: 7697632)
21. P16 is a useful supplemental diagnostic marker of pulmonary small cell carcinoma in small biopsies and cytology specimens.
Švajdler M; Mezencev R; Ondič O; Šašková B; Mukenšnábl P; Michal M
Ann Diagn Pathol; 2018 Apr; 33():23-29. PubMed ID: 29566943
[TBL] [Abstract][Full Text] [Related]
22. Molecular genetic characterization of neuroendocrine lung cancer cell lines.
Lai SL; Brauch H; Knutsen T; Johnson BE; Nau MM; Mitsudomi T; Tsai CM; Whang-Peng J; Zbar B; Kaye FJ
Anticancer Res; 1995; 15(2):225-32. PubMed ID: 7762988
[TBL] [Abstract][Full Text] [Related]
23. Advances in the analysis of chromosome alterations in human lung carcinomas.
Testa JR; Liu Z; Feder M; Bell DW; Balsara B; Cheng JQ; Taguchi T
Cancer Genet Cytogenet; 1997 May; 95(1):20-32. PubMed ID: 9140450
[TBL] [Abstract][Full Text] [Related]
24. Chromosomal alterations, biological features and in vitro chemosensitivity of SCLC-R1, a new cell line from human metastatic small cell lung carcinoma.
Gasperi-Campani A; Roncuzzi L; Zoli W; Lenzi L; Gruppioni R; Sensi A; Zini N; Farabegoli F; Amadori D
Eur J Cancer; 1998 Apr; 34(5):724-30. PubMed ID: 9713281
[TBL] [Abstract][Full Text] [Related]
25. Stepwise genetic changes associated with progression of nontumorigenic HPV-18 immortalized human prostate cancer-derived cell line to a malignant phenotype.
Hukku B; Mally M; Cher ML; Peehl DM; Kung H; Rhim JS
Cancer Genet Cytogenet; 2000 Jul; 120(2):117-26. PubMed ID: 10942801
[TBL] [Abstract][Full Text] [Related]
26. Genetic alterations in early-stage pulmonary large cell neuroendocrine carcinoma.
Hiroshima K; Iyoda A; Shibuya K; Haga Y; Toyozaki T; Iizasa T; Nakayama T; Fujisawa T; Ohwada H
Cancer; 2004 Mar; 100(6):1190-8. PubMed ID: 15022286
[TBL] [Abstract][Full Text] [Related]
27. Establishment of a human small cell lung carcinoma cell line carrying amplification of c-myc gene and chromosomal translocation of t(3p;6p) and t(12q;17p).
Kato A; Kamiyama T; Yamaguchi S; Sudo K; Mori S; Sekiguchi M; Aoki N; Shibuya M
Jpn J Cancer Res; 1993 Apr; 84(4):355-9. PubMed ID: 8390424
[TBL] [Abstract][Full Text] [Related]
28. Molecular cytogenetic analysis of oral squamous cell carcinomas by comparative genomic hybridization, spectral karyotyping, and fluorescence in situ hybridization.
Uchida K; Oga A; Okafuji M; Mihara M; Kawauchi S; Furuya T; Chochi Y; Ueyama Y; Sasaki K
Cancer Genet Cytogenet; 2006 Jun; 167(2):109-16. PubMed ID: 16737909
[TBL] [Abstract][Full Text] [Related]
29. Small cell lung cancer: etiology, biology, clinical features, staging, and treatment.
Cook RM; Miller YE; Bunn PA
Curr Probl Cancer; 1993; 17(2):69-141. PubMed ID: 8395998
[TBL] [Abstract][Full Text] [Related]
30. Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines.
Kim SK; Su LK; Oh Y; Kemp BL; Hong WK; Mao L
Oncogene; 1998 Jan; 16(1):89-93. PubMed ID: 9467947
[TBL] [Abstract][Full Text] [Related]
31. Lack of expression of aminoacylase-1 in small cell lung cancer. Evidence for inactivation of genes encoded by chromosome 3p.
Miller YE; Minna JD; Gazdar AF
J Clin Invest; 1989 Jun; 83(6):2120-4. PubMed ID: 2542383
[TBL] [Abstract][Full Text] [Related]
32. A frequent deletion of chromosome 5q21 in advanced small cell and non-small cell carcinoma of the lung.
Hosoe S; Ueno K; Shigedo Y; Tachibana I; Osaki T; Kumagai T; Tanio Y; Kawase I; Nakamura Y; Kishimoto T
Cancer Res; 1994 Apr; 54(7):1787-90. PubMed ID: 7907944
[TBL] [Abstract][Full Text] [Related]
33. Allelotype and replication error phenotype of small cell lung carcinoma.
Kawanishi M; Kohno T; Otsuka T; Adachi J; Sone S; Noguchi M; Hirohashi S; Yokota J
Carcinogenesis; 1997 Nov; 18(11):2057-62. PubMed ID: 9395202
[TBL] [Abstract][Full Text] [Related]
34. Establishment and characterization of five human small cell lung cancer cell lines from early tumor xenografts.
Arvelo F; Poupon MF; Le Chevalier T
Anticancer Res; 1994; 14(5A):1893-901. PubMed ID: 7847823
[TBL] [Abstract][Full Text] [Related]
35. Chromosome abnormalities in 10 lung cancer cell lines of the NCI-H series analyzed with spectral karyotyping.
Grigorova M; Lyman RC; Caldas C; Edwards PA
Cancer Genet Cytogenet; 2005 Oct; 162(1):1-9. PubMed ID: 16157194
[TBL] [Abstract][Full Text] [Related]
36. [Comparative genomic hybridization of bronchial carcinomas and their metastases].
Petersen I; Petersen S; Bockmühl U; Schwendel A; Wolf G; Dietel M
Verh Dtsch Ges Pathol; 1997; 81():297-305. PubMed ID: 9474883
[TBL] [Abstract][Full Text] [Related]
37. Del(5q) is associated with clinical and histological parameters in small cell neuroendocrine lung carcinoma.
Hartel PH; Shackelford AL; Hartel JV; Wenger SL
Int J Surg Pathol; 2008 Oct; 16(4):419-23. PubMed ID: 18508840
[TBL] [Abstract][Full Text] [Related]
38. Integrative genomic analysis of small-cell lung carcinoma reveals correlates of sensitivity to bcl-2 antagonists and uncovers novel chromosomal gains.
Olejniczak ET; Van Sant C; Anderson MG; Wang G; Tahir SK; Sauter G; Lesniewski R; Semizarov D
Mol Cancer Res; 2007 Apr; 5(4):331-9. PubMed ID: 17426248
[TBL] [Abstract][Full Text] [Related]
39. Cytogenetic, spectral karyotyping, fluorescence in situ hybridization, and comparative genomic hybridization characterization of two new secondary leukemia cell lines with 5q deletions, and MYC and MLL amplification.
Knutsen T; Pack S; Petropavlovskaja M; Padilla-Nash H; Knight C; Mickley LA; Ried T; Elwood PC; Roberts SJ
Genes Chromosomes Cancer; 2003 Jul; 37(3):270-81. PubMed ID: 12759925
[TBL] [Abstract][Full Text] [Related]
40. Comparison between fluorescence in situ hybridization and classical cytogenetics in human tumors.
Virmani AK; Tonk VS; Gazdar AF
Anticancer Res; 1998; 18(3A):1351-6. PubMed ID: 9673339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
